Home > Cashflow Statement > CORONA REMEDIES

CORONA REMEDIES
Net Cash Inflow / Outflow

    Back to Cashflow Statement
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Net Cash Inflow / Outflow ₹-1.39 Cr₹0.06 Cr₹-11 Cr₹7.71 Cr

What is the latest Net Cash Inflow / Outflow ratio of CORONA REMEDIES ?

The latest Net Cash Inflow / Outflow ratio of CORONA REMEDIES is ₹-1.39 Cr based on Mar2026 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2026₹-1.39 Cr
Mar2025₹0.06 Cr
Mar2024₹-11 Cr
Mar2023₹7.71 Cr

How is Net Cash Inflow / Outflow of CORONA REMEDIES Trending?

Years Net Cash Inflow / Outflow % Change
Mar2026 ₹-1.39 Cr
Negative
Mar2025 ₹0.06 Cr
Positive
Mar2024 ₹-11 Cr
Negative
Mar2023 ₹7.71 Cr -

Compare Net Cash Inflow / Outflow of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹14,460.6 Cr -0.8% 17.3% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹454,914.0 Cr 3.9% 7.8% 13% Stock Analytics
DIVIS LABORATORIES ₹300,380.0 Cr 11.5% 20.6% 68% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,169.0 Cr 1% 1.8% 34.3% Stock Analytics
DR REDDYS LABORATORIES ₹114,933.0 Cr 1.1% 11.8% 14.9% Stock Analytics
CIPLA ₹114,478.0 Cr 1.1% 7.9% -6.3% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-0.8%

17.3%

NA
SENSEX

5.9%

13%

-1.9%


You may also like the below Video Courses